Endocan Expression Correlated with Total Volume of Coronary Artery Dilation in Patients with Coronary Artery Ectasia

Overview

Journal Postepy Kardiol Interwencyjnej

Publisher Termedia

Specialty Cardiology & Vascular Diseases

Date 2021 Feb 18

PMID 33597994

Citations 3

Authors

Iwanczyk Sylwia

Aleksander Araszkiewicz

Michal Borger

Mikolaj Kaminski

Michal Wrotynski

Ewa Chmara

Artur Cieslewicz

Artur Radziemski

Maciej Lesiak

Affiliations

Soon will be listed here.

Abstract

Introduction: Inflammation and angiogenesis disturbances are considered as factors contributing to the development of coronary artery ectasias (CAE). Endocan (endothelial cell-specific molecule-1 - ESM-1) regulates both inflammatory and angiogenetic processes. However, there are no data about the correlation between endocan level and the severity of CAE measured with total volume of coronary artery dilation.

Aim: To assess whether the severity of the inflammatory process measured as endocan concentration correlates with the total volume of CAE.

Material And Methods: We selected prospectively a total of 43 consecutive patients with coronary artery ectasia from 2240 patients who underwent coronary angiography in our center. Determination of endocan was performed by using the Human Endothelial cell-specific Molecule 1 (ECSM1/ENDOCAN) ELISA Kit. 3D QCA (three-dimensional quantitative coronary angiography) was used for coronary lesion and aneurysm quantification. The total volume of dilation was defined as the volume of all aneurysms and ectasias of coronary arteries in 1 patient.

Results: The mean volume of all aneurysms in 1 patient was 677 ±878.7 mm. The total aneurysm volume was positively strongly correlated with endocan concentration (Pearson correlation coefficient: 0.811; 2-tailed < 0.001).

Conclusions: Endocan is a potential marker of vascular wall damage mainly as a result of inflammation in the course of atherosclerosis, but also vascular remodeling as a result of a disturbance of pro- and anti-angiogenic processes. Endocan level reflects the intensity of the above processes and therefore correlates with the severity of CAE, measured as the total volume of dilation.

Citing Articles

Coronary Artery Aneurysm or Ectasia as a Form of Coronary Artery Remodeling: Etiology, Pathogenesis, Diagnostics, Complications, and Treatment.

Wozniak P, Iwanczyk S, Blaszyk M, Stepien K, Lesiak M, Mularek-Kubzdela T Biomedicines. 2024; 12(9).

PMID: 39335497 PMC: 11428638. DOI: 10.3390/biomedicines12091984.

Involvement of Angiogenesis in the Pathogenesis of Coronary Aneurysms.

Iwanczyk S, Lehmann T, Cieslewicz A, Radziemski A, Malesza K, Wrotynski M Biomedicines. 2021; 9(9).

PMID: 34572455 PMC: 8469881. DOI: 10.3390/biomedicines9091269.

Three-dimensional reconstruction of conventional catheter angiography-identified coronary artery aneurysms and ectasias.

Chmiel J, Malinowski K, Ksiazek K, Wnuk G, Dradrach J, Proniewska K Cardiol J. 2021; 28(4):623-626.

PMID: 33843038 PMC: 8277012. DOI: 10.5603/CJ.a2021.0038.

References

Leschka S, Alkadhi H, Plass A, Desbiolles L, Grunenfelder J, Marincek B . Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur Heart J. 2005; 26(15):1482-7. DOI: 10.1093/eurheartj/ehi261. View

Markis J, Joffe C, Cohn P, Feen D, Herman M, Gorlin R . Clinical significance of coronary arterial ectasia. Am J Cardiol. 1976; 37(2):217-22. DOI: 10.1016/0002-9149(76)90315-5. View

Swaye P, Fisher L, Litwin P, Vignola P, JUDKINS M, Kemp H . Aneurysmal coronary artery disease. Circulation. 1983; 67(1):134-8. DOI: 10.1161/01.cir.67.1.134. View

Shin J, Huggenberger R, Detmar M . Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood. 2008; 112(6):2318-26. PMC: 2532805. DOI: 10.1182/blood-2008-05-156331. View

Turhan H, Erbay A, Saatci Yasar A, Aksoy Y, Bicer A, Yetkin G . Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia. Coron Artery Dis. 2005; 16(1):45-50. DOI: 10.1097/00019501-200502000-00009. View

Paulus P, Jennewein C, Zacharowski K . Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?. Biomarkers. 2011; 16 Suppl 1:S11-21. DOI: 10.3109/1354750X.2011.587893. View

Greil G, Stuber M, Botnar R, Kissinger K, Geva T, Newburger J . Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Circulation. 2002; 105(8):908-11. DOI: 10.1161/hc0802.105563. View

Li J, Nie S, Qian X, Zeng H, Zhang C . Chronic inflammatory status in patients with coronary artery ectasia. Cytokine. 2009; 46(1):61-4. DOI: 10.1016/j.cyto.2008.12.012. View

Lassalle P, Molet S, Janin A, Heyden J, Tavernier J, Fiers W . ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996; 271(34):20458-64. DOI: 10.1074/jbc.271.34.20458. View

10.

Glagov S, WEISENBERG E, Zarins C, Stankunavicius R, Kolettis G . Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987; 316(22):1371-5. DOI: 10.1056/NEJM198705283162204. View

11.

Tunick P, Slater J, Kronzon I, Glassman E . Discrete atherosclerotic coronary artery aneurysms: a study of 20 patients. J Am Coll Cardiol. 1990; 15(2):279-82. DOI: 10.1016/s0735-1097(10)80049-x. View

12.

Savino M, Parisi Q, Biondi-Zoccai G, Pristipino C, Cianflone D, Crea F . New insights into molecular mechanisms of diffuse coronary ectasiae: a possible role for VEGF. Int J Cardiol. 2005; 106(3):307-12. DOI: 10.1016/j.ijcard.2005.01.025. View

13.

Galis Z, Sukhova G, Lark M, Libby P . Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994; 94(6):2493-503. PMC: 330083. DOI: 10.1172/JCI117619. View

14.

Balta S, Mikhailidis D, Demirkol S, Ozturk C, Celik T, Iyisoy A . Endocan: A novel inflammatory indicator in cardiovascular disease?. Atherosclerosis. 2015; 243(1):339-43. DOI: 10.1016/j.atherosclerosis.2015.09.030. View

15.

Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P . Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol. 2004; 43(4):649-52. DOI: 10.1016/j.jacc.2003.08.052. View

16.

Nishioka T, Luo H, Eigler N, Berglund H, Kim C, Siegel R . Contribution of inadequate compensatory enlargement to development of human coronary artery stenosis: an in vivo intravascular ultrasound study. J Am Coll Cardiol. 1996; 27(7):1571-6. DOI: 10.1016/0735-1097(96)00071-x. View

17.

Soto M, Reyes-Villatoro M, Marquez R, Cardoso G, Posadas-Sanchez R, Juarez-Orozco L . Evaluation and analysis of plasma soluble adhesion molecules in patients with coronary ectasia and atherosclerotic coronary artery disease. Arch Med Res. 2014; 45(6):478-83. DOI: 10.1016/j.arcmed.2014.07.002. View

18.

Pasterkamp G, Wensing P, Post M, Hillen B, Mali W, Borst C . Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation. 1995; 91(5):1444-9. DOI: 10.1161/01.cir.91.5.1444. View

19.

Henney A, Wakeley P, Davies M, Foster K, Hembry R, Murphy G . Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991; 88(18):8154-8. PMC: 52465. DOI: 10.1073/pnas.88.18.8154. View

20.

Balta S, Ozturk C . The Relation between CD40 Ligand and Coronary Artery Disease. Cardiology. 2015; 131(2):107-8. DOI: 10.1159/000381180. View